ProMIS Neurosciences Chief Development Officer Johanne Kaplan acquires 2,280 common shares worth $30,324
PMN•Insider share purchase
- ProMIS Neurosciences Chief Development Officer Johanne Kaplan bought 2,280 common shares at $13.30 each.
- Kaplan’s direct ownership rose to 6,221 common shares following the purchase.
